Diabetes is a "chronic metabolic disorder characterised by elevated blood glucose (or blood sugar) levels." Diabetes develops when the immune system, the body's defence system against infection, assaults and destroys the pancreas' insulin-producing beta cells. The most prevalent kind of diabetes is caused by a combination of factors, including genetics and lifestyle choices. An endocrinologist is a doctor who has had specialised training and experience in the treatment of diabetic patients. Diabetologists only treat diabetic patients who are in the early or advanced phases of the polygenic disease, whereas endocrinologists treat patients with medical specialties.
The Scientific Event will take place in Tokyo and will cover a wide range of topics in Diabetes and Endocrinology, such as Hypoglycemia, Diabetic Ketoacidosis, Cardiovascular Diseases, Diabetic Retinopathy, Diabetic Neuropathy, Diabetic Nephropathy, and so on, through Keynote talks, Exhibitions, Symposia, Workshops, and Speaker sessions. Diabetes 2023 aims to give visitors with a range of diabetes-related information and tools. Our conference's main theme is “Exploring Diabetes and Endocrinology's Recent Trends and Emerging Challenges”.
Learning does not weary the mind. Learning is not something that happens by chance; it is something that must be pursued with desire and adhered to with perseverance. Conferences are designed to bring people together, connect them to ideas, and connect them to possibilities. The overarching goal is to shape the future of research in order to shape the world's future. Hilaris Conferences are the key to opening the doors of transformation while seeking information from specialists. Various and innovative Conferences on a wide range of study areas will provide everyone with a one-of-a-kind learning and professional experience.
The main purpose of Diabetes 2023 is to bring together Keynote Speakers, Delegates, Scientists, Doctors, Researchers, Academicians, and Young Research Forums in order to exchange prior knowledge and abilities in the field of diabetes. At this conference, speakers and delegates will share, discuss, debate, and deconstruct creative and scientific knowledge. We sincerely hope that this conference will take into account and debate all elements of "Systematic research of Diabetes and Endocrinology" so that we can all work together to make the world a better and healthier place.
The conference will focus on Hypoglycemia, Diabetic Ketoacidosis, Cardiovascular Diseases, Diabetic Retinopathy, Diabetic Neuropathy, Diabetic Nephropathy, Gestational Diabetes, Epedemiology, Hyperglycemic Hyperosmolar Nonketotic Syndrome, Macrovascular and Microvascular complications such as Cerebrovascular diseases, coronary artery diseases, peripheral vascular diseases, micro aneurysms, intraretinal haemorrhage, hard exudates, focal capillary closure.
Why to attend International Conference and Expo on Diabetes and Endocrinology:
The focus of Diabetes and Endocrinology 2023 will be on how science and medicine connect with the pharmacological and physiological functions. We will be able to communicate, discuss, and debate themes relating to Diabetes and its related diseases by attending this conference. This is a superb opportunity for outstanding Organizing Committee Members and Keynote Speakers to share their previous expertise and experience with individuals from all around the world. This is once-in-a-lifetime opportunity for speakers to network with all of the attendees and scholars by publishing their works.
Target Audience:
Endocrinologists | Cardiologists | Nephrologists |Nutritionists | Dieticians | Diabetes Health Professionals | Physicians | Nurse Practitioners | Health Care Analysts | Doctors | Academic researchers | Professors |Students |Research Institutes | Business delegates |Young Researchers |Advertising and Promotion Agency Executive | Professionals in the media sector | Medical colleges | Diabetes Societies & Associations | Medical & Pharmaceutical Companies | Medical devices & companies.
Associations and Societies:
American Diabetes Association | World Diabetes Foundation |International Diabetes Federation | Diabetes worldwide - French Healthcare association | German diabetes association | Romanian federation of diabetes | Association for Program Directors in Endocrinology | Diabetes and Metabolism | European Neuroendocrine Tumour Society | European Society for Paediatric Endocrinology | National Diabetes Organization | The Endocrine Society of India | Asian Association of Endocrine Surgeons South Asian Federation of Endocrine Societies | Metabolism and Reproduction | Endocrine and Metabolic Society of Singapore Malaysian Endocrine and Metabolic Society.
Market analysis:
The global diabetic devices market is expected to reach roughly US$ 48.8 billion by 2030, up from US$ 28.30 billion in 2021, with a compound annual growth rate (CAGR) of 6.2 percent from 2021 to 2030. Factors such as the rising prevalence of diabetes, as well as technical improvements and new product releases, are driving the market. Global health expenditure on diabetes is predicted to reach USD 490 billion in 2030, up from USD 376 billion in 2010, according to the NCBI analysis. Obesity, sedentary lifestyles, and the fast food culture are just a few of the reasons influencing market growth. Obesity is at an all-time high in this country, with one out of every three people being fat, and the figure is anticipated to rise to 50 percent by 2030. The market is being transformed by a growing number of new market players. With the use of artificial intelligence technologies, new market entrants focus on patient convenience. The growing knowledge of diabetes and diabetes care among the general public is driving up demand for diabetes devices all around the world. Companion Medical launched Inpen, the first smart insulin pen solution in the United States, in December 2017. It's the only FDA-approved system that combines insulin injector pens and a smartphone app. The widespread availability of numerous novel medication delivery methods, such as pen injections, jet injectors, and pumps, has fueled the worldwide diabetes devices market's rise.
